TxCell SA, a publicly listed biotechnology company that develops platforms for innovative, personalized T cell immunotherapies for the treatment of... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=95932&sid=2
PRWeb 2016-06-25 HistoryIT to provide Utrecht University's Media and Culture Studies Expertise Centre with hands-on digital heritage projects... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=527907
The European Commission has granted marketing authorization for Gilead Sciences' once-daily single tablet regimen (STR) Odefsey (emtricitabine 200... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=95931&sid=2
Europital will be present at the Clinical Trials Innovation Programme on the 27th of June at the Radisson Blu Hotel Hamburg Airport, in Hamburg,... ...http://www.pressreleasepoint.com/europital-will-provide-key-presentation-ctip-congress-hamburg-germany
PenThu®, the first Interactive Guidance Management System (IGMS) in the clinical research industry developed by Europital, has reached a new... ...http://www.pressreleasepoint.com/penthu-compliant-fda-21-cfr-part-11-and-eu-annex-11
INNOVATION AND RESEARCH IN HUMARN...
We, NEXGEN CENTRE OF EXCELLENCE...